ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 133 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 1.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2013 | $505,000 | – | 65,640 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 10,500,000 | $17,955,000 | 0.87% |
SENZAR ASSET MANAGEMENT, LLC | 1,872,191 | $3,201,447,000 | 0.70% |
Virtus ETF Advisers LLC | 277,607 | $475,000 | 0.35% |
GLOBEFLEX CAPITAL L P | 571,500 | $977,000 | 0.27% |
Lyons Wealth Management, LLC. | 42,408 | $73,000 | 0.11% |
TFS CAPITAL LLC | 222,736 | $381,000 | 0.07% |
Jacobi Capital Management LLC | 35,000 | $56,000 | 0.03% |
Renaissance Technologies | 5,601,355 | $9,578,000 | 0.02% |
WELLINGTON MANAGEMENT GROUP LLP | 26,725,936 | $45,701,000 | 0.01% |
PRELUDE CAPITAL MANAGEMENT, LLC | 46,300 | $79,000 | 0.01% |